呼吸系統疾病檢測市場規模、佔有率、成長分析（按檢測類型、按應用、按地區）- 按行業預測，2024-2031 年

2022年全球呼吸系統疾病檢測市場規模為61.7億美元，從2023年的63.4億美元成長到2031年的78.4億美元，預計在預測期內（2024-2031年）將以複合年成長率成長。 %。

由於氣喘、慢性阻塞性肺病和肺癌等呼吸道疾病的盛行率不斷上升，而污染、吸菸和人口老化又加劇了這種疾病，全球呼吸道疾病檢測市場正在強勁成長。借助分子診斷、免疫檢測和診斷成像技術進步，檢測效率和檢測結果得到提高，增加了準確診斷方法的緊迫性。 COVID-19 大流行進一步凸顯了呼吸系統檢測的重要性，並推動了對包括 PCR 和抗原檢測在內的各種檢測方法的需求。然而，挑戰依然存在，包括檢測成本高昂限制了低收入地區的檢測、缺乏意識以及基礎設施不足，特別是在發展中地區。此外，監管障礙可能會阻礙創新和產品發布，突顯需要採取教育舉措來加深對測試在患者照護中關鍵作用的理解。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究

呼吸系統疾病檢測市場規模：依檢測類型

• 市場概況
• 機械測試
  • 肺活量測定法
  • 峰值流量測試
  • 肺功能檢查
  • 血氣測試
  • 其他
• 影像檢查
  • X光
  • 電腦斷層掃描
  • 超音波檢查
  • MRI
• 體外診斷測試
  • 照護現場測試
  • 分子診斷測試

呼吸系統疾病檢測市場規模：依應用分類

• 市場概況
• 慢性阻塞性肺病
• 肺癌
• 氣喘
• 結核
• 其他

按最終用途分類的呼吸系統疾病檢測市場規模

• 市場概況
• 醫院
• 醫生診所
• 臨床實驗室

呼吸系統疾病檢測市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Beckton Dickinson and Company
• Koninklijke Philips NV
• ResMed Inc.
• Medtronic
• MG Diagnostic Corporation
• Abbott
• ThermoFisher Scientific
• Biomerieux
• QIAGEN
• Seimens Healthineers AG
• F. Hoffmann-La Roche Ltd
• SDI Diagnostics
• BD
• Niterra Co., Ltd.
• QuantuMDx Group Ltd.
• COSMED srl
• Bird Healthcare
• visby medical
• Seegene Inc
• Bio-Rad Laboratories Inc

結論和建議

Global Respiratory Disease Testing Market size was valued at USD 6.17 billion in 2022 and is poised to grow from USD 6.34 billion in 2023 to USD 7.84 billion by 2031, growing at a CAGR of 2.7% during the forecast period (2024-2031).

The global respiratory disease testing market has witnessed robust growth, fueled by the rising prevalence of respiratory conditions like asthma, COPD, and lung cancer, exacerbated by pollution, smoking, and aging populations. The urgency for accurate diagnostic methods has escalated, supported by technological advancements in molecular diagnostics, immunoassays, and imaging, which enhance testing efficiency and outcomes. The COVID-19 pandemic further underscored the importance of respiratory testing, driving demand for diverse testing methods, including PCR and antigen tests. However, challenges remain, including high testing costs limiting access in low-income areas, awareness deficits, and inadequate infrastructure, particularly in developing regions. Additionally, regulatory hurdles may impede innovation and product launches, emphasizing the need for educational initiatives to enhance understanding of testing's critical role in patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Respiratory Disease Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Respiratory Disease Testing Market Segmental Analysis

Global Respiratory Disease Testing Market is segmented by test type, application, end-use and region. Based on test type, the market is segmented into mechanical tests, imaging tests and in-vitro diagnostic tests. Based on application, the market is segmented into chronic obstructive pulmonary disease, lung cancer, asthma, tuberculosis and other. Based on end-use, the market is segmented into hospital, physicians clinic and clinical laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Respiratory Disease Testing Market

The global respiratory disease testing market is primarily driven by the escalating incidence of respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. Contributing factors such as environmental pollution, tobacco use, and an aging population are exacerbating the prevalence of these diseases worldwide. This surge in respiratory health issues underscores the urgent necessity for reliable and effective testing solutions, prompting healthcare providers and patients alike to seek out advanced diagnostic tools. As the demand for precise testing continues to rise, the respiratory disease testing market is expected to experience significant growth in response to these pressing public health challenges.

Restraints in the Global Respiratory Disease Testing Market

The Global Respiratory Disease Testing market faces significant restraints due to rigorous regulatory approval processes. The complexity involved in navigating these regulations can create substantial hurdles for market participants. Securing the necessary approvals for new testing technologies often requires extensive time and financial resources, resulting in prolonged delays for product launches. This situation not only stifles innovation but also restricts the ability of companies to introduce cutting-edge solutions to the market. Consequently, the challenging regulatory landscape may inhibit the overall growth and advancement of the respiratory disease testing sector, limiting potential improvements in patient care and disease management.

Market Trends of the Global Respiratory Disease Testing Market

The Global Respiratory Disease Testing market is witnessing a notable trend towards increased emphasis on point-of-care testing (POCT), which facilitates swift diagnosis and immediate treatment decisions directly at the patient's location. This surge in demand is largely fueled by the need for rapid and precise results, particularly within critical care environments and resource-constrained areas, where traditional laboratory testing may be less feasible. As healthcare providers prioritize quick turnaround times to enhance patient outcomes, the adoption of innovative point-of-care testing devices and platforms is expected to rise significantly, marking a transformative shift in respiratory disease management and testing approaches globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Respiratory Disease Testing Market Size by Test Type & CAGR (2024-2031)

• Market Overview
• Mechanical Tests
  • Spirometry
  • Peak-Flow Test
  • Pulmonary Function Test
  • Blood Gas Test
  • Others
• Imaging Tests
  • X-Ray
  • Ct-Scan
  • Ultrasonography
  • Mri
• In-Vitro Diagnostic Tests
  • Point-Of-Care Test
  • Molecular Diagnostic Test

Global Respiratory Disease Testing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Chronic Obstructive Pulmonary Disease
• Lung Cancer
• Asthma
• Tuberculosis
• Other

Global Respiratory Disease Testing Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Hospital
• Physicians Clinic
• Clinical Laboratories

Global Respiratory Disease Testing Market Size & CAGR (2024-2031)

• North America (Test Type, Application, End-Use)
  • USA
  • Canada
• Europe (Test Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Beckton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MG Diagnostic Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoFisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seimens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SDI Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Niterra Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COSMED srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bird Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• visby medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation